These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31758209)

  • 61. Intermittent bilateral deep brain stimulation of the nucleus accumbens shell reduces intravenous methamphetamine intake and seeking in Wistar rats.
    Batra V; Tran TL; Caputo J; Guerin GF; Goeders NE; Wilden J
    J Neurosurg; 2017 Apr; 126(4):1339-1350. PubMed ID: 27392268
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement.
    Everett NA; McGregor IS; Baracz SJ; Cornish JL
    Neuropharmacology; 2018 May; 133():1-11. PubMed ID: 29353054
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chronic methamphetamine self-administration alters cognitive flexibility in male rats.
    Cox BM; Cope ZA; Parsegian A; Floresco SB; Aston-Jones G; See RE
    Psychopharmacology (Berl); 2016 Jun; 233(12):2319-27. PubMed ID: 27037939
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
    Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
    Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.
    Tunstall BJ; Ho CP; Cao J; Vendruscolo JCM; Schmeichel BE; Slack RD; Tanda G; Gadiano AJ; Rais R; Slusher BS; Koob GF; Newman AH; Vendruscolo LF
    Neuropharmacology; 2018 Mar; 131():96-103. PubMed ID: 29217282
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oxytocin Acts in Nucleus Accumbens to Attenuate Methamphetamine Seeking and Demand.
    Cox BM; Bentzley BS; Regen-Tuero H; See RE; Reichel CM; Aston-Jones G
    Biol Psychiatry; 2017 Jun; 81(11):949-958. PubMed ID: 28110822
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward.
    Anggadiredja K; Sakimura K; Hiranita T; Yamamoto T
    Brain Res; 2004 Sep; 1021(2):272-6. PubMed ID: 15342276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Escalation of methamphetamine self-administration in adolescent and adult rats.
    Anker JJ; Baron TR; Zlebnik NE; Carroll ME
    Drug Alcohol Depend; 2012 Jul; 124(1-2):149-53. PubMed ID: 22305912
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats.
    Reichel CM; Chan CH; Ghee SM; See RE
    Psychopharmacology (Berl); 2012 Oct; 223(4):371-80. PubMed ID: 22592902
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.
    Sim MS; Soga T; Pandy V; Wu YS; Parhar IS; Mohamed Z
    Metab Brain Dis; 2017 Dec; 32(6):1767-1783. PubMed ID: 28681200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cerebrovascular Injury After Serial Exposure to Chronic Stress and Abstinence from Methamphetamine Self-Administration.
    Natarajan R; Mitchell CM; Harless N; Yamamoto BK
    Sci Rep; 2018 Jul; 8(1):10558. PubMed ID: 30002494
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sex- and Brain Region-specific Changes in Gene Expression in Male and Female Rats as Consequences of Methamphetamine Self-administration and Abstinence.
    Daiwile AP; Jayanthi S; Cadet JL
    Neuroscience; 2021 Jan; 452():265-279. PubMed ID: 33242543
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Replacement treatment during extinction training with the atypical dopamine uptake inhibitor, JHW-007, reduces relapse to methamphetamine seeking.
    Dassanayake AF; Canales JJ
    Neurosci Lett; 2018 Apr; 671():88-92. PubMed ID: 29452175
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.
    Ruda-Kucerova J; Babinska Z; Stark T; Micale V
    Neurotox Res; 2017 Jul; 32(1):121-133. PubMed ID: 28421529
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown.
    Gonçalves J; Leitão RA; Higuera-Matas A; Assis MA; Coria SM; Fontes-Ribeiro C; Ambrosio E; Silva AP
    Brain Behav Immun; 2017 May; 62():306-317. PubMed ID: 28237710
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The vagus nerve mediates the suppressing effects of peripherally administered oxytocin on methamphetamine self-administration and seeking in rats.
    Everett NA; Turner AJ; Costa PA; Baracz SJ; Cornish JL
    Neuropsychopharmacology; 2021 Jan; 46(2):297-304. PubMed ID: 32450570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Isradipine, an L-type calcium channel inhibitor, attenuates cue-associated methamphetamine-seeking in mice.
    Choi S; Methiwala HN; Graves SM
    Brain Res; 2023 Nov; 1818():148528. PubMed ID: 37567548
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reciprocal inhibitory effects of intravenous d-methamphetamine self-administration and wheel activity in rats.
    Miller ML; Vaillancourt BD; Wright MJ; Aarde SM; Vandewater SA; Creehan KM; Taffe MA
    Drug Alcohol Depend; 2012 Feb; 121(1-2):90-6. PubMed ID: 21899959
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic cathinone derivatives in rats.
    Xu P; Lai M; Fu D; Liu H; Wang Y; Shen H; Zhou W
    Pharmacol Biochem Behav; 2021 Apr; 203():173128. PubMed ID: 33515585
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neuroadaptations in the dentate gyrus following contextual cued reinstatement of methamphetamine seeking.
    Takashima Y; Fannon MJ; Galinato MH; Steiner NL; An M; Zemljic-Harpf AE; Somkuwar SS; Head BP; Mandyam CD
    Brain Struct Funct; 2018 Jun; 223(5):2197-2211. PubMed ID: 29441405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.